NeurAxis, Inc.
AMEX:NRXSBiotechnology
+$0.29 today
- Market cap
- $69.12M
- Beta
- 1.41
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.67
Volume 0.23M
Average 0.18M
NRXS Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
NeurAxis, Inc.AMEX: NRXS
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin grows, but more slowly than its trailing trend
Q1 FY2026 selling, general & admin of $3.03M rose 1.3% year over year, behind the +5.1% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 31.8% from the prior quarter. Over 3 fiscal years it compounded at +23.2% a year.
Context
- Selling, general & admin amounted to 289.8% of revenue in FY2025, down 55.5 pp from a year earlier.
- Selling, general & admin increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $21.49M (+107.8%) for the fiscal year ending Dec 2026, a step up from the +11.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $3.03M+31.8% QoQ
- Last fiscal yearDec 2025
- $10.34M+11.5% YoY
- LTMMar 2026
- $10.38M+5.1% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 10.34M USD
- Year-over-year change
- +11.5%
- 4-year CAGR
- +19.8%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.34M | +11.5% |
| FY2024 | 2024-12-31 | 9.27M | +7.2% |
| FY2023 | 2023-12-31 | 8.65M | +56.3% |
| FY2022 | 2022-12-31 | 5.53M | +10.2% |
| FY2021 | 2021-12-31 | 5.02M | — |
Selling, General & Admin vs competitors
How NRXS compares with its peers on the latest reported figures
- NRXS's LTM Mar 2026 selling, general & admin of $10.38M is the 3rd highest of the 4 companies compared; the peer median is $16.24M.
- Its year-over-year change of +5.1% is the 3rd highest of 4, against a peer median of +18.2%.
- Selling, general & admin amounts to 242.5% of revenue for NRXS, versus a peer median of 1893.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $11.42B | +118480.6% | -4.1% | — | |
| LTM Mar 2026 | $16.24M | -4.1% | -19.2% | 1893.0% | |
NRXSNeurAxis, Inc. | LTM Mar 2026 | $10.38M | +5.1% | +23.2% | 242.5% |
| LTM Dec 2025 | $5.69M | +18.2% | -5.3% | — | |
| Peer median (excluding NRXS) | $16.24M | +18.2% | -5.3% | 1893.0% | |
Competitors are the stored peer set for NRXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.72M | 2.68M | 2.46M | 2.69M | 3.57M |
| Cost of Revenue | 467.66K | 297.06K | 303.35K | 362K | 562.92K |
| Gross Profit | 2.25M | 2.39M | 2.16M | 2.32M | 3.01M |
| Gross Margin | 82.8% | 88.9% | 87.7% | 86.5% | 84.2% |
| Research & Development | 203.41K | 225.61K | 169.32K | 206.11K | 493.61K |
| Selling, General & Admin | 5.02M | 5.53M | 8.65M | 9.27M | 10.34M |
| Operating Expenses | 5.22M | 5.76M | 8.82M | 9.48M | 10.84M |
| Depreciation & Amortization | 36.71K | 37.13K | 40.73K | 37.83K | 59.5K |
| EBITDA | (2.95M) | (4.33M) | (9.23M) | (7.9M) | (7.67M) |
| EBITDA Margin | -108.6% | -161.1% | -375.1% | -294.2% | -214.8% |
| Operating Income | (2.97M) | (3.37M) | (6.66M) | (7.16M) | (7.83M) |
| Operating Margin | -109.1% | -125.6% | -270.9% | -266.5% | -219.4% |
| Interest Income | 0 | (2.32M) | (2.77K) | 0 | 0 |
| Interest Expense | 36.93K | 417.6K | 5.36M | 300.72K | 73.97K |
| Other Income / Expenses | (58K) | (1.41M) | (7.96M) | (1.08M) | 29.35K |
| Income Before Tax | (3.03M) | (4.78M) | (14.63M) | (8.24M) | (7.8M) |
| Pre-Tax Margin | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (3.03M) | (4.78M) | (14.63M) | (8.24M) | (7.8M) |
| Net Margin | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |
| EPS (Basic) | (0.62) | (0.57) | (2.32) | (1.22) | (0.95) |
| EPS (Diluted) | (0.62) | (0.78) | (2.32) | (1.22) | (0.95) |
| Weighted Avg Shares | 5.38M | 8.41M | 6.3M | 6.92M | 9.08M |
| Weighted Avg Shares (Diluted) | 5.38M | 8.41M | 6.3M | 6.92M | 9.08M |
NeurAxis, Inc.
AMEX:NRXS
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.